Presenter: David W. Newton, BS Pharm, PhD, FAPhA
Date Presentation Originally Occurred: Wednesday, April 21, 2021
Time: On Demand. Will be available until April 21, 2023
Pharmacogenomics, PGx, Overview includes selected milestones in the first 60-years of PGx, types and naming of genetically derived cytochrome P450 or CYP hepatic drug metabolizing enzymes, DNA single nucleotide polymorphisms or SNPs (“snips”) resulting in CYP phenotypes that cause from excessively fast to normal to excessively slow to absent drug metabolism, and clinical examples of the effects on psychiatric and other drugs from CYP phenotypes, and inducers and inhibitors of particular CYPs.
To Receive 1.0 Advanced Pharmacotherapy contact hour:
For this webinar, ISPN has been approved for one (1) Advanced Pharmacotherapy contact hour from the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (OBN-001-91). After attending the webinar, please complete the post webinar test and evaluation.
Criteria for Successful Completion
To obtain one Advanced Pharmacotherapy contact hour, one must attend the entire webinar, pass a post-webinar test with a score of 78% or higher, and complete a post-webinar evaluation.
Conflict of Interest
There is no conflict of interest for anyone with the ability to control content for this activity.
Activity Approval Statement
This activity has been approved by the Ohio Nurses Association to award contact hours. The Ohio Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. (OBN-001-91).
Activity Number: 2020-0000001105
To receive ISPN member pricing, please login to the members only section of the website.
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
|Quantity||Price per voucher|